Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-01-04
2010-12-14
Loewe, Sun Jae Y. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S364700
Reexamination Certificate
active
07851500
ABSTRACT:
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof. The formula (I) compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents.
REFERENCES:
patent: WO 2004/009601 (2004-01-01), None
Bender et al., caplus an 2004:905786.
Dayam, et al., Expert Opinion on Therapeutic Patents, vol. 17, No. 1, pp. 83-102 (2007).
Dodier Marco
Marinier Anne
Quesnelle Claude A.
Bristol--Myers Squibb Company
Korsen Elliott
Loewe Sun Jae Y.
LandOfFree
Aminopyrazole kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminopyrazole kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminopyrazole kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4222700